LUTETIUM LU 177 DOTATATE

LUTETIUM LU 177 DOTATATE was reported 5819 times

LUTETIUM LU 177 DOTATATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD CATECHOLAMINES 1 0.5000
1 NEUROENDOCRINE TUMOUR OF THE RECTUM 12 0.3750
2 NEUROENDOCRINE TUMOUR METASTATIC 3 0.3333
3 SMALL INTESTINE NEUROENDOCRINE TUMOUR 18 0.3273
4 GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOUR DISEASE 27 0.2432
5 ACTH-PRODUCING PITUITARY TUMOUR 2 0.1538
6 CARCINOID HEART DISEASE 13 0.1429
7 ANAPLASTIC MENINGIOMA 4 0.1379
8 CARCINOID CRISIS 30 0.1327
9 PANCREATIC NEUROENDOCRINE TUMOUR 78 0.1217
10 PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC 23 0.0962
11 CARCINOID TUMOUR OF THE LIVER 2 0.0833
12 NEUROENDOCRINE TUMOUR 103 0.0727
13 GASTROINTESTINAL NEUROENDOCRINE CARCINOMA 2 0.0690
14 CARCINOID SYNDROME 23 0.0635
15 PARAGANGLION NEOPLASM 9 0.0616
16 GASTROINTESTINAL NEUROENDOCRINE TUMOUR 4 0.0615
17 5-HYDROXYINDOLACETIC ACID IN URINE 1 0.0588
18 NEUROENDOCRINE TUMOUR OF THE LUNG METASTATIC 3 0.0556
19 BENIGN NEOPLASM OF EYELID 1 0.0556
20 HEPATIC NEUROENDOCRINE TUMOUR 2 0.0541
21 CATECHOLAMINE CRISIS 2 0.0541
22 CARCINOID TUMOUR IN THE LARGE INTESTINE 1 0.0526
23 CARCINOID TUMOUR OF THE DUODENUM 1 0.0476
24 NEUROENDOCRINE TUMOUR OF THE LUNG 5 0.0463
25 INSULINOMA 8 0.0452
26 AESTHESIONEUROBLASTOMA 1 0.0435
27 METASTATIC CARCINOID TUMOUR 4 0.0385
28 BLOOD CHROMOGRANIN A INCREASED 17 0.0370
29 PCO2 ABNORMAL 2 0.0345
30 NEUROENDOCRINE CARCINOMA METASTATIC 8 0.0325
31 5-HYDROXYINDOLACETIC ACID INCREASED 2 0.0308
32 ILL-DEFINED DISORDER 1542 0.0254
33 EXPOSURE TO RADIATION 3 0.0238
34 BLOOD GASTRIN INCREASED 3 0.0234
35 ENDOCRINE PANCREATIC DISORDER 1 0.0233
36 BASE EXCESS INCREASED 2 0.0225
37 SARS-COV-2 TEST 2 0.0211
38 BENIGN LYMPH NODE NEOPLASM 2 0.0204
39 CARCINOID TUMOUR OF THE APPENDIX 1 0.0185
40 ACUTE OESOPHAGEAL MUCOSAL LESION 1 0.0182
41 5-HYDROXYINDOLACETIC ACID IN URINE INCREASED 1 0.0182
42 CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT 2 0.0168
43 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 2 0.0164
44 METASTASES TO PANCREAS 7 0.0158
45 NEUROENDOCRINE CARCINOMA 10 0.0145
46 PORTAL VEIN OCCLUSION 2 0.0137
47 METASTASES TO STOMACH 5 0.0128
48 PITUITARY APOPLEXY 2 0.0114
49 MONOCYTE PERCENTAGE INCREASED 8 0.0113
50 GENERAL PHYSICAL HEALTH DETERIORATION 1294 0.0112
51 BLOOD CORTICOTROPHIN INCREASED 3 0.0104
52 AMINO ACID LEVEL ABNORMAL 1 0.0103
53 METASTASES TO HEART 3 0.0099
54 CARCINOID TUMOUR OF THE SMALL BOWEL 1 0.0096
55 TUMOUR NECROSIS 10 0.0095
56 MARGINAL ZONE LYMPHOMA 2 0.0093
57 METASTASES TO BREAST 3 0.0090
58 CEREBROSPINAL FLUID RETENTION 1 0.0085
59 BONE MARROW TUMOUR CELL INFILTRATION 1 0.0085
60 MALIGNANT PERITONEAL NEOPLASM 5 0.0085
61 SERUM SEROTONIN INCREASED 3 0.0085
62 NEUROGENIC BOWEL 2 0.0084
63 CARCINOID TUMOUR PULMONARY 2 0.0083
64 INTESTINAL METASTASIS 3 0.0083
65 ABDOMINAL WALL MASS 1 0.0082
66 CARCINOID TUMOUR 6 0.0081
67 BED BUG INFESTATION 1 0.0079
68 BONE MARROW INFILTRATION 3 0.0078
69 HYPERPROTEINAEMIA 2 0.0076
70 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS ABNORMAL 1 0.0075
71 HAEMORRHAGIC ASCITES 2 0.0070
72 HEPATIC CANCER METASTATIC 6 0.0070
73 PSYCHOSEXUAL DISORDER 2 0.0069
74 DUODENAL OBSTRUCTION 2 0.0067
75 CHONDROSARCOMA 1 0.0063
76 HAEMATOLOGY TEST ABNORMAL 2 0.0062
77 LYMPHOCYTE PERCENTAGE DECREASED 8 0.0060
78 LABORATORY TEST ABNORMAL 174 0.0059
79 TUMOUR FLARE 4 0.0059
80 METASTASES TO LIVER 103 0.0059
81 BLOOD OESTROGEN ABNORMAL 1 0.0058
82 ANION GAP DECREASED 2 0.0057
83 LIVER FUNCTION TEST DECREASED 2 0.0056
84 HYPOGLYCAEMIC SEIZURE 5 0.0055
85 BILIARY OBSTRUCTION 7 0.0054
86 BRAIN SCAN ABNORMAL 3 0.0054
87 HEPATIC INFARCTION 2 0.0053
88 ALVEOLAR LUNG DISEASE 1 0.0053
89 BLOOD CHLORIDE INCREASED 9 0.0052
90 HEPATIC LESION 22 0.0051
91 LIVER ABSCESS 16 0.0049
92 SARS-COV-2 TEST POSITIVE 65 0.0049
93 BLOOD BILIRUBIN DECREASED 3 0.0049
94 BENIGN BONE NEOPLASM 1 0.0048
95 PYRAMIDAL TRACT SYNDROME 2 0.0048
96 VAGINAL ULCERATION 2 0.0048
97 METASTASES TO PELVIS 3 0.0047
98 SYSTOLIC HYPERTENSION 2 0.0046
99 PHAEOCHROMOCYTOMA 3 0.0046
100 GALLBLADDER RUPTURE 2 0.0043
101 BLOOD BICARBONATE INCREASED 2 0.0042
102 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
103 PERFORMANCE STATUS DECREASED 19 0.0041
104 METASTASES TO ABDOMINAL CAVITY 2 0.0041
105 BLOOD UREA DECREASED 5 0.0040
106 HERPES ZOSTER OTICUS 2 0.0039
107 CHROMOSOME ANALYSIS ABNORMAL 1 0.0039
108 VERTEBRAL LESION 2 0.0039
109 DUMPING SYNDROME 1 0.0038
110 RETROPERITONEAL LYMPHADENOPATHY 2 0.0038
111 BONE CANCER METASTATIC 2 0.0038
112 CHOLANGITIS INFECTIVE 1 0.0038
113 EOSINOPHIL PERCENTAGE INCREASED 2 0.0037
114 ENTEROCOLITIS BACTERIAL 1 0.0036
115 BLOOD PH INCREASED 2 0.0036
116 STARVATION 3 0.0036
117 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 2 0.0036
118 MONOCYTE COUNT INCREASED 13 0.0036
119 SUPERFICIAL VEIN THROMBOSIS 3 0.0036
120 MALIGNANT NEOPLASM PROGRESSION 364 0.0036
121 CARDIO-RESPIRATORY DISTRESS 1 0.0035
122 OPHTHALMIC HERPES SIMPLEX 2 0.0035
123 ADNEXA UTERI MASS 1 0.0035
124 CATHETER SITE HAEMATOMA 1 0.0034
125 SECOND PRIMARY MALIGNANCY 28 0.0034
126 PROTHROMBIN TIME RATIO DECREASED 2 0.0032
127 SPIDER VEIN 2 0.0031
128 PYELOCALIECTASIS 3 0.0031
129 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
130 METASTASES TO BONE 50 0.0030
131 HEPATIC PAIN 13 0.0030
132 CHRONIC MYELOMONOCYTIC LEUKAEMIA 2 0.0030
133 ADMINISTRATION SITE EXTRAVASATION 3 0.0030
134 ABDOMINAL MASS 8 0.0030
135 METASTASES TO LYMPH NODES 20 0.0030
136 CARBON DIOXIDE INCREASED 4 0.0029
137 METASTASES TO PLEURA 3 0.0029
138 UTERINE PROLAPSE 3 0.0028
139 LYMPHOCYTE COUNT DECREASED 47 0.0027
140 CHOLANGITIS ACUTE 2 0.0026
141 BASOPHIL COUNT INCREASED 2 0.0026
142 MALIGNANT ASCITES 2 0.0026
143 CARBON DIOXIDE DECREASED 3 0.0026
144 MONOCYTE COUNT DECREASED 3 0.0025
145 HORMONE LEVEL ABNORMAL 12 0.0025
146 MEAN CELL HAEMOGLOBIN INCREASED 4 0.0024
147 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
148 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 4 0.0024
149 MEAN PLATELET VOLUME DECREASED 2 0.0024
150 METASTASES TO PERITONEUM 6 0.0024
151 INTESTINAL ISCHAEMIA 13 0.0024
152 CANCER PAIN 6 0.0023
153 ABDOMINAL SEPSIS 2 0.0023
154 BLADDER HYPERTROPHY 1 0.0023
155 OBSTRUCTION 9 0.0023
156 BLOOD CREATININE DECREASED 7 0.0022
157 CONGESTIVE HEPATOPATHY 1 0.0022
158 ANASTOMOTIC ULCER 1 0.0022
159 ENCEPHALITIS 15 0.0022
160 PLATELET COUNT DECREASED 231 0.0022
161 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
162 BILIARY SEPSIS 1 0.0022
163 TUMOUR LYSIS SYNDROME 19 0.0022
164 BLOOD ALBUMIN DECREASED 17 0.0021
165 PROTHROMBIN TIME SHORTENED 3 0.0021
166 ECZEMA ASTEATOTIC 1 0.0021
167 INVESTIGATION ABNORMAL 3 0.0021
168 BLAST CELLS PRESENT 1 0.0021
169 BLOOD CREATINE ABNORMAL 1 0.0021
170 BLOOD URIC ACID DECREASED 1 0.0021
171 DUODENAL STENOSIS 1 0.0021
172 RED BLOOD CELL COUNT ABNORMAL 3 0.0020
173 ARTERIOVENOUS FISTULA 1 0.0020
174 MYELODYSPLASTIC SYNDROME 29 0.0020
175 CORNEAL SCAR 1 0.0020
176 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
177 BLADDER OBSTRUCTION 1 0.0019
178 EXTRAVASATION 8 0.0019
179 BLOOD CHLORIDE DECREASED 5 0.0019
180 ASCITES 57 0.0019
181 GASTROINTESTINAL PERFORATION 8 0.0019
182 BLOOD SODIUM ABNORMAL 2 0.0019
183 VASCULAR CALCIFICATION 2 0.0019
184 ALBUMINURIA 1 0.0019
185 PANCREATIC MASS 2 0.0019
186 PROTEIN TOTAL DECREASED 7 0.0019
187 ACUTE LEUKAEMIA 3 0.0019
188 OESOPHAGEAL VARICES HAEMORRHAGE 4 0.0018
189 BLADDER DILATATION 2 0.0018
190 CLAUSTROPHOBIA 2 0.0018
191 SMALL INTESTINE CARCINOMA 4 0.0018
192 METASTASES TO SPINE 6 0.0018
193 CONCOMITANT DISEASE AGGRAVATED 11 0.0018
194 CHOLANGITIS 11 0.0018
195 BACTERIURIA 1 0.0018
196 ACUTE MYELOID LEUKAEMIA 27 0.0017
197 RADIATION SKIN INJURY 2 0.0017
198 DILATATION ATRIAL 2 0.0017
199 GLOMERULAR FILTRATION RATE DECREASED 21 0.0017
200 LYMPHOPENIA 24 0.0017
201 HAEMATOTOXICITY 16 0.0017
202 BLEEDING TIME PROLONGED 2 0.0017
203 ILLNESS 167 0.0016
204 BILIARY TRACT INFECTION 1 0.0016
205 HEPATIC NECROSIS 6 0.0016
206 RADIOTHERAPY 3 0.0016
207 BLOOD BILIRUBIN ABNORMAL 2 0.0016
208 ENDOCRINE DISORDER 2 0.0016
209 HEPATIC MASS 3 0.0016
210 CONCOMITANT DISEASE PROGRESSION 3 0.0015
211 ANISOCYTOSIS 1 0.0015
212 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
213 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
214 ANION GAP INCREASED 2 0.0015
215 FULL BLOOD COUNT DECREASED 30 0.0015
216 BODY MASS INDEX INCREASED 2 0.0015
217 DISEASE PROGRESSION 174 0.0015
218 BILIARY TRACT DISORDER 2 0.0014
219 DISCHARGE 2 0.0014
220 SUBILEUS 3 0.0014
221 ANAEMIA MACROCYTIC 3 0.0014
222 HEART VALVE INCOMPETENCE 4 0.0014
223 METASTATIC NEOPLASM 6 0.0014
224 BONE LESION 5 0.0014
225 BITE 1 0.0014
226 DYSLALIA 1 0.0014
227 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
228 FAILURE TO THRIVE 7 0.0013
229 AXILLARY PAIN 2 0.0013
230 GASTROINTESTINAL WALL THICKENING 2 0.0013
231 PLATELET COUNT ABNORMAL 8 0.0013
232 BLOOD UREA INCREASED 22 0.0013
233 COAGULATION TEST ABNORMAL 1 0.0013
234 SMALL INTESTINAL OBSTRUCTION 16 0.0013
235 MEAN CELL VOLUME DECREASED 2 0.0013
236 DISSEMINATED INTRAVASCULAR COAGULATION 18 0.0013
237 ABDOMINAL SYMPTOM 1 0.0012
238 CARTILAGE ATROPHY 1 0.0012
239 CARDIAC VALVE DISEASE 7 0.0012
240 SEBORRHOEIC DERMATITIS 2 0.0012
241 CAMPYLOBACTER INFECTION 1 0.0012
242 NEUTROPHIL COUNT INCREASED 12 0.0012
243 MEAN CELL VOLUME INCREASED 3 0.0012
244 CACHEXIA 6 0.0012
245 PHYSICAL DECONDITIONING 3 0.0012
246 LEUKAEMIA 11 0.0012
247 THROMBOCYTOPENIA 130 0.0012
248 HYPOALBUMINAEMIA 9 0.0012
249 CARDIAC OUTPUT DECREASED 1 0.0011
250 COVID-19 198 0.0011
251 BLOOD PRESSURE SYSTOLIC INCREASED 22 0.0011
252 PROTEIN TOTAL INCREASED 3 0.0011
253 METASTASES TO LUNG 13 0.0011
254 PRODUCT CONTAMINATION 4 0.0011
255 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
256 WHITE BLOOD CELL DISORDER 3 0.0011
257 METASTASIS 8 0.0011
258 BLOOD ALKALINE PHOSPHATASE ABNORMAL 1 0.0011
259 CERUMEN IMPACTION 1 0.0011
260 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
261 ANEURYSM RUPTURED 1 0.0011
262 INTESTINAL OBSTRUCTION 41 0.0011
263 ELECTRIC SHOCK SENSATION 3 0.0011
264 DRUG TOLERANCE DECREASED 3 0.0011
265 FLANK PAIN 10 0.0011
266 SMALL INTESTINAL PERFORATION 2 0.0011
267 BLOOD UREA ABNORMAL 1 0.0011
268 BRAIN STEM HAEMORRHAGE 1 0.0011
269 BLOOD BICARBONATE DECREASED 2 0.0011
270 HYPOPROTEINAEMIA 2 0.0011
271 TUMOUR HAEMORRHAGE 3 0.0011
272 TUMOUR MARKER INCREASED 5 0.0010
273 GINGIVAL RECESSION 2 0.0010
274 SPINAL CORD COMPRESSION 4 0.0010
275 BICYTOPENIA 2 0.0010
276 DUODENAL PERFORATION 1 0.0010
277 RED BLOOD CELL COUNT DECREASED 29 0.0010
278 HAEMATOCRIT DECREASED 20 0.0010
279 CELL DEATH 2 0.0010
280 BLOOD TEST ABNORMAL 14 0.0010
281 BONE MARROW DISORDER 3 0.0010
282 HYPOGLYCAEMIA 48 0.0010
283 VITAMIN B12 DEFICIENCY 4 0.0010
284 CHANGE OF BOWEL HABIT 2 0.0010
285 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
286 CORONAVIRUS TEST POSITIVE 1 0.0010
287 PANCYTOPENIA 54 0.0010
288 AXILLARY MASS 1 0.0010
289 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
290 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
291 NEUROGENIC BLADDER 2 0.0009
292 FULL BLOOD COUNT ABNORMAL 10 0.0009
293 POLYMYALGIA RHEUMATICA 3 0.0009
294 ENTERITIS 6 0.0009
295 HYDRONEPHROSIS 7 0.0009
296 BONE NEOPLASM 1 0.0009
297 HEPATIC NEOPLASM 3 0.0009
298 HEPATOMEGALY 9 0.0009
299 AORTIC DILATATION 1 0.0009
300 PROSTATE CANCER METASTATIC 3 0.0009
301 CARDIAC HYPERTROPHY 1 0.0009
302 HEPATIC FAILURE 27 0.0009
303 ADENOCARCINOMA 2 0.0009
304 CYTOGENETIC ABNORMALITY 1 0.0009
305 ILEUS 11 0.0009
306 CHOLECYSTITIS ACUTE 5 0.0009
307 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
308 BLOOD FIBRINOGEN DECREASED 1 0.0009
309 BLOODY DISCHARGE 1 0.0009
310 JAUNDICE CHOLESTATIC 3 0.0008
311 EOSINOPHIL COUNT DECREASED 2 0.0008
312 BILE DUCT STENOSIS 1 0.0008
313 NEOPLASM PROGRESSION 29 0.0008
314 WEIGHT ABNORMAL 2 0.0008
315 CYTOPENIA 10 0.0008
316 GENERALISED OEDEMA 10 0.0008
317 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
318 MYELOSUPPRESSION 29 0.0008
319 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 1 0.0008
320 BRONCHIAL SECRETION RETENTION 1 0.0008
321 NEUTROPHIL COUNT DECREASED 32 0.0008
322 ADENOCARCINOMA PANCREAS 1 0.0008
323 DRUG CLEARANCE DECREASED 1 0.0008
324 ENCEPHALITIS AUTOIMMUNE 1 0.0008
325 HEPATIC ENCEPHALOPATHY 7 0.0007
326 WEIGHT BEARING DIFFICULTY 2 0.0007
327 WRONG PRODUCT ADMINISTERED 5 0.0007
328 CORNEAL OPACITY 1 0.0007
329 CLONUS 2 0.0007
330 ULCERATIVE KERATITIS 2 0.0007
331 RED BLOOD CELL COUNT INCREASED 2 0.0007
332 CHOLECYSTITIS INFECTIVE 2 0.0007
333 BODY TEMPERATURE DECREASED 7 0.0007
334 BLOOD BILIRUBIN INCREASED 19 0.0007
335 PANCREATIC CARCINOMA METASTATIC 2 0.0007
336 PRODUCT SUPPLY ISSUE 5 0.0007
337 PARAPLEGIA 2 0.0007
338 ESCHERICHIA SEPSIS 2 0.0007
339 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 16 0.0007
340 WRONG PATIENT RECEIVED PRODUCT 2 0.0007
341 GROIN PAIN 6 0.0007
342 BILIARY DILATATION 1 0.0007
343 TOOTH DISCOLOURATION 2 0.0007
344 COCCYDYNIA 1 0.0007
345 CHOLECYSTITIS 8 0.0007
346 VASCULAR DEVICE INFECTION 3 0.0007
347 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
348 FIBROSIS 2 0.0006
349 RENAL FUNCTION TEST ABNORMAL 3 0.0006
350 RENAL IMPAIRMENT 54 0.0006
351 INFUSION SITE EXTRAVASATION 4 0.0006
352 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
353 TRICUSPID VALVE INCOMPETENCE 5 0.0006
354 BILE DUCT STONE 2 0.0006
355 WHITE BLOOD CELL COUNT ABNORMAL 4 0.0006
356 INTESTINAL PERFORATION 7 0.0006
357 MOUTH ULCERATION 13 0.0006
358 PANCREATIC DISORDER 3 0.0006
359 LIVER DISORDER 27 0.0006
360 MUCOUS STOOLS 3 0.0006
361 ABDOMINAL TENDERNESS 3 0.0006
362 PEPTIC ULCER 2 0.0006
363 ANXIETY DISORDER 2 0.0006
364 ABDOMINAL PAIN 137 0.0006
365 ENTERITIS INFECTIOUS 1 0.0006
366 FEMORAL NECK FRACTURE 3 0.0006
367 MUSCULOSKELETAL CHEST PAIN 9 0.0006
368 APLASIA PURE RED CELL 2 0.0006
369 FLUSHING 59 0.0006
370 RESPIRATION ABNORMAL 4 0.0006
371 ACUTE SINUSITIS 1 0.0006
372 BLOOD CREATININE ABNORMAL 2 0.0006
373 HYPERREFLEXIA 2 0.0006
374 WHITE BLOOD CELL COUNT DECREASED 62 0.0006
375 BURNS SECOND DEGREE 1 0.0006
376 INCONTINENCE 6 0.0006
377 BLOOD CREATININE INCREASED 37 0.0006
378 NEUTROPENIC SEPSIS 4 0.0006
379 JAUNDICE 15 0.0006
380 HAEMOGLOBIN DECREASED 57 0.0006
381 CEREBRAL VENOUS THROMBOSIS 1 0.0006
382 FAECES SOFT 4 0.0005
383 OESOPHAGITIS 6 0.0005
384 THROMBOCYTOSIS 2 0.0005
385 BODY TEMPERATURE ABNORMAL 1 0.0005
386 LEUKOPENIA 27 0.0005
387 CARDIAC DYSFUNCTION 2 0.0005
388 PLATELET COUNT INCREASED 7 0.0005
389 MALNUTRITION 6 0.0005
390 HEPATIC FUNCTION ABNORMAL 20 0.0005
391 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
392 BLOOD CALCIUM DECREASED 6 0.0005
393 ANAEMIA 100 0.0005
394 QUALITY OF LIFE DECREASED 7 0.0005
395 DEVICE RELATED INFECTION 8 0.0005
396 ELECTROLYTE IMBALANCE 6 0.0005
397 EARLY SATIETY 1 0.0005
398 HYPOVOLAEMIA 3 0.0005
399 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
400 DEATH 441 0.0005
401 APLASIA 1 0.0005
402 PROSTATOMEGALY 2 0.0005
403 DECREASED INTEREST 3 0.0005
404 DECREASED APPETITE 118 0.0005
405 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
406 LETHARGY 29 0.0005
407 AZOTAEMIA 2 0.0005
408 BLOOD POTASSIUM DECREASED 15 0.0005
409 RECURRENT CANCER 2 0.0005
410 AKINESIA 1 0.0005
411 ASPARTATE AMINOTRANSFERASE INCREASED 25 0.0005
412 CD4 LYMPHOCYTES DECREASED 1 0.0005
413 PROCTALGIA 3 0.0005
414 HAEMOGLOBIN ABNORMAL 3 0.0005
415 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
416 HORDEOLUM 2 0.0005
417 FAECES DISCOLOURED 10 0.0005
418 TONGUE DISCOLOURATION 2 0.0005
419 DIVERTICULUM INTESTINAL 2 0.0005
420 BIPOLAR I DISORDER 1 0.0005
421 VULVOVAGINAL DISCOMFORT 2 0.0005
422 THERAPY PARTIAL RESPONDER 7 0.0004
423 NEPHROPATHY TOXIC 5 0.0004
424 URINARY TRACT DISORDER 2 0.0004
425 FEEDING DISORDER 9 0.0004
426 ULCER HAEMORRHAGE 3 0.0004
427 BLOOD LOSS ANAEMIA 1 0.0004
428 CHRONIC MYELOID LEUKAEMIA 2 0.0004
429 MASS 6 0.0004
430 BILIRUBIN CONJUGATED INCREASED 1 0.0004
431 BLOOD SODIUM DECREASED 8 0.0004
432 MULTIPLE ORGAN DYSFUNCTION SYNDROME 12 0.0004
433 CARDIAC TAMPONADE 2 0.0004
434 HYPOVOLAEMIC SHOCK 2 0.0004
435 SUBCUTANEOUS ABSCESS 2 0.0004
436 LIVER FUNCTION TEST ABNORMAL 12 0.0004
437 KIDNEY INFECTION 8 0.0004
438 INFLAMMATORY MARKER INCREASED 2 0.0004
439 HEPATIC ENZYME ABNORMAL 2 0.0004
440 HYPERAMMONAEMIA 2 0.0004
441 FLUID INTAKE REDUCED 2 0.0004
442 LACRIMATION INCREASED 12 0.0004
443 EMPHYSEMA 4 0.0004
444 SEPSIS 44 0.0004
445 PATHOLOGICAL FRACTURE 2 0.0004
446 BONE MARROW FAILURE 8 0.0004
447 BOWEL MOVEMENT IRREGULARITY 3 0.0004
448 HYPERGLYCAEMIA 14 0.0004
449 PETECHIAE 4 0.0004
450 MALABSORPTION 2 0.0004
451 RENAL CYST 3 0.0004
452 ANORECTAL DISCOMFORT 2 0.0004
453 BLOOD DISORDER 3 0.0004
454 LIVER FUNCTION TEST INCREASED 8 0.0004
455 OVERWEIGHT 2 0.0004
456 ANAL ABSCESS 2 0.0004
457 BLOOD SODIUM INCREASED 1 0.0004
458 DECUBITUS ULCER 3 0.0004
459 CHOLESTASIS 7 0.0004
460 ERUCTATION 7 0.0004
461 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
462 NEUTROPENIA 49 0.0004
463 PRODUCT LEAKAGE 2 0.0004
464 EJACULATION DISORDER 1 0.0004
465 DYSPNOEA AT REST 1 0.0003
466 BILIARY COLIC 1 0.0003
467 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
468 URINE OUTPUT DECREASED 3 0.0003
469 NAIL DISORDER 3 0.0003
470 INTENTIONAL PRODUCT USE ISSUE 30 0.0003
471 BLOOD CALCIUM INCREASED 3 0.0003
472 HIP FRACTURE 11 0.0003
473 SPINAL PAIN 4 0.0003
474 PURPURA 3 0.0003
475 LYMPHADENOPATHY 12 0.0003
476 PERITONITIS 7 0.0003
477 SYMPTOM RECURRENCE 2 0.0003
478 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 60 0.0003
479 MALAISE 146 0.0003
480 CEREBROVASCULAR DISORDER 1 0.0003
481 CENTRAL VENOUS CATHETERISATION 1 0.0003
482 GASTROINTESTINAL CARCINOMA 3 0.0003
483 MOOD ALTERED 9 0.0003
484 EMBOLISM VENOUS 1 0.0003
485 NOCTURIA 4 0.0003
486 INGUINAL HERNIA 2 0.0003
487 DIABETIC FOOT 1 0.0003
488 BRAIN NEOPLASM 3 0.0003
489 DUODENITIS 1 0.0003
490 BLOOD GLUCOSE ABNORMAL 6 0.0003
491 HYPERCALCAEMIA 4 0.0003
492 PIGMENTATION DISORDER 2 0.0003
493 NASAL DRYNESS 2 0.0003
494 ABDOMINAL ADHESIONS 1 0.0003
495 HAEMATEMESIS 8 0.0003
496 STOMATITIS 19 0.0003
497 HEART RATE DECREASED 11 0.0003
498 WEIGHT DECREASED 87 0.0003
499 CUSHINGOID 1 0.0003
500 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
501 METASTASES TO CENTRAL NERVOUS SYSTEM 4 0.0003
502 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
503 INCOHERENT 2 0.0003
504 BLOOD POTASSIUM INCREASED 5 0.0003
505 VITAMIN D DEFICIENCY 3 0.0003
506 RENAL TUBULAR NECROSIS 3 0.0003
507 HYPOKALAEMIA 14 0.0003
508 PERICARDIAL EFFUSION 7 0.0003
509 CORONAVIRUS INFECTION 2 0.0003
510 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
511 POST-TRAUMATIC STRESS DISORDER 2 0.0003
512 NAUSEA 236 0.0003
513 TOXIC SKIN ERUPTION 3 0.0003
514 BREAST MASS 2 0.0003
515 PRODUCT ADMINISTRATION ERROR 6 0.0003
516 PLEURAL EFFUSION 18 0.0003
517 PNEUMONITIS 8 0.0003
518 ABNORMAL LOSS OF WEIGHT 2 0.0003
519 DIARRHOEA 189 0.0003
520 INFARCTION 2 0.0003
521 POOR VENOUS ACCESS 3 0.0003
522 CHRONIC KIDNEY DISEASE 22 0.0003
523 LYMPHOEDEMA 2 0.0003
524 TENDERNESS 3 0.0003
525 HYPOMAGNESAEMIA 4 0.0003
526 ORTHOSTATIC HYPOTENSION 5 0.0003
527 HYPERKALAEMIA 10 0.0003
528 EATING DISORDER 6 0.0003
529 VOMITING 132 0.0003
530 PELVIC PAIN 5 0.0003
531 CHOLELITHIASIS 9 0.0003
532 CUTANEOUS VASCULITIS 1 0.0003
533 HEPATITIS 7 0.0003
534 BLOOD PHOSPHORUS DECREASED 1 0.0003
535 MELAENA 6 0.0003
536 HYPOPHOSPHATAEMIA 2 0.0003
537 URINARY INCONTINENCE 8 0.0003
538 THERAPY NON-RESPONDER 12 0.0003
539 CHRONIC SINUSITIS 1 0.0003
540 AUTOIMMUNE THYROIDITIS 1 0.0003
541 FLATULENCE 15 0.0003
542 CHEMOTHERAPY 1 0.0003
543 ACIDOSIS 2 0.0003
544 LIPASE INCREASED 2 0.0003
545 NEOPLASM 3 0.0003
546 DRY EYE 13 0.0003
547 MENINGIOMA 4 0.0003
548 ORAL HERPES 5 0.0003
549 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
550 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
551 ACCIDENT 3 0.0003
552 ACUTE KIDNEY INJURY 38 0.0002
553 NIGHT SWEATS 8 0.0002
554 FATIGUE 193 0.0002
555 TACHYCARDIA 22 0.0002
556 ABNORMAL FAECES 2 0.0002
557 PRODUCT USE IN UNAPPROVED INDICATION 60 0.0002
558 AORTIC DISSECTION 1 0.0002
559 EOSINOPHIL COUNT INCREASED 2 0.0002
560 SYNCOPE 24 0.0002
561 DYSPNOEA EXERTIONAL 9 0.0002
562 FACE OEDEMA 4 0.0002
563 RENAL DISORDER 11 0.0002
564 AORTIC VALVE INCOMPETENCE 1 0.0002
565 ABSCESS LIMB 1 0.0002
566 FACIAL PARALYSIS 2 0.0002
567 ALOPECIA 46 0.0002
568 CARDIAC MURMUR 2 0.0002
569 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
570 BONE CANCER 1 0.0002
571 NODULE 3 0.0002
572 BLOOD GLUCOSE DECREASED 11 0.0002
573 SPINAL OSTEOARTHRITIS 2 0.0002
574 HYPOXIA 8 0.0002
575 ABDOMINAL ABSCESS 1 0.0002
576 BLOOD CREATINE INCREASED 1 0.0002
577 BLOOD PRESSURE DECREASED 15 0.0002
578 HEPATOTOXICITY 5 0.0002
579 BRAIN NEOPLASM MALIGNANT 1 0.0002
580 PANCREATITIS ACUTE 5 0.0002
581 OEDEMA PERIPHERAL 27 0.0002
582 CHROMATURIA 5 0.0002
583 TACHYPNOEA 3 0.0002
584 ABDOMINAL DISTENSION 23 0.0002
585 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
586 ACUTE HEPATIC FAILURE 3 0.0002
587 DISEASE COMPLICATION 1 0.0002
588 DYSURIA 8 0.0002
589 HUNGER 3 0.0002
590 NEPHROPATHY 2 0.0002
591 DEVICE OCCLUSION 3 0.0002
592 PHOTOPHOBIA 4 0.0002
593 ARTERIOSCLEROSIS 2 0.0002
594 HYPOCALCAEMIA 4 0.0002
595 SINUS TACHYCARDIA 3 0.0002
596 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
597 LOWER LIMB FRACTURE 4 0.0002
598 ACUTE RESPIRATORY FAILURE 4 0.0002
599 HYPERCHOLESTEROLAEMIA 2 0.0002
600 ATELECTASIS 2 0.0002
601 HERNIA 4 0.0002
602 SEPTIC SHOCK 9 0.0002
603 CONSTIPATION 45 0.0002
604 PYREXIA 71 0.0002
605 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
606 RENAL FAILURE 27 0.0002
607 PULMONARY MASS 3 0.0002
608 HAEMORRHAGE INTRACRANIAL 3 0.0002
609 AGEUSIA 5 0.0002
610 CARDIAC FAILURE 16 0.0002
611 ABDOMINAL PAIN UPPER 41 0.0002
612 CORONARY ARTERY STENOSIS 1 0.0002
613 BLOOD COUNT ABNORMAL 3 0.0002
614 DRUG TOLERANCE 1 0.0002
615 MOTOR DYSFUNCTION 2 0.0002
616 AMMONIA INCREASED 1 0.0002
617 HYPOPHAGIA 5 0.0002
618 ENDOCARDITIS 1 0.0002
619 INITIAL INSOMNIA 2 0.0002
620 ASTHENIA 73 0.0002
621 TEMPERATURE INTOLERANCE 2 0.0002
622 HYPERBILIRUBINAEMIA 2 0.0002
623 HAEMATOMA 5 0.0002
624 TOOTH LOSS 4 0.0002
625 CARDIAC DISORDER 18 0.0002
626 APLASTIC ANAEMIA 1 0.0002
627 HERPES ZOSTER 11 0.0002
628 INJECTION SITE DISCOMFORT 2 0.0002
629 OSTEOARTHRITIS 8 0.0002
630 RENAL PAIN 2 0.0002
631 HYPOTHYROIDISM 6 0.0002
632 RETCHING 4 0.0002
633 DEHYDRATION 25 0.0002
634 ANAL FISTULA 1 0.0002
635 COMPRESSION FRACTURE 1 0.0002
636 ANAL FISSURE 1 0.0002
637 RECTAL HAEMORRHAGE 8 0.0002
638 DECREASED ACTIVITY 2 0.0002
639 DRY MOUTH 15 0.0002
640 DIABETES MELLITUS 14 0.0002
641 CYSTIC FIBROSIS 1 0.0002
642 DIVERTICULITIS 5 0.0002
643 TRANSAMINASES INCREASED 4 0.0002
644 URINARY RETENTION 6 0.0002
645 NEOPLASM MALIGNANT 12 0.0002
646 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
647 HYPOTENSION 36 0.0002
648 PLASMA CELL MYELOMA 7 0.0002
649 ORAL PAIN 4 0.0002
650 CELLULITIS 9 0.0002
651 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
652 ACUTE PULMONARY OEDEMA 1 0.0002
653 MITRAL VALVE INCOMPETENCE 2 0.0002
654 BACK PAIN 41 0.0002
655 CIRCULATORY COLLAPSE 3 0.0002
656 MYOCARDIAL ISCHAEMIA 2 0.0002
657 SCAR 3 0.0002
658 GASTRIC HAEMORRHAGE 2 0.0002
659 PANCREATIC CARCINOMA 5 0.0002
660 DELIRIUM 6 0.0002
661 MUSCULOSKELETAL PAIN 9 0.0002
662 NEEDLE ISSUE 5 0.0002
663 VASCULITIS 2 0.0002
664 BLOOD GLUCOSE INCREASED 32 0.0002
665 BACTERAEMIA 2 0.0002
666 CEREBRAL HAEMORRHAGE 6 0.0002
667 ROAD TRAFFIC ACCIDENT 7 0.0002
668 GOUT 3 0.0002
669 CONTUSION 16 0.0002
670 OEDEMA 9 0.0002
671 HEPATITIS C 2 0.0002
672 DRUG INTOLERANCE 16 0.0002
673 APHASIA 5 0.0002
674 LOCALISED INFECTION 4 0.0002
675 C-REACTIVE PROTEIN INCREASED 6 0.0002
676 LOSS OF CONSCIOUSNESS 21 0.0002
677 LIVER INJURY 4 0.0002
678 NECK PAIN 9 0.0002
679 SECRETION DISCHARGE 2 0.0002
680 MUSCLE ATROPHY 2 0.0002
681 OFF LABEL USE 137 0.0002
682 METABOLIC ACIDOSIS 5 0.0002
683 PULMONARY OEDEMA 7 0.0002
684 C-REACTIVE PROTEIN ABNORMAL 1 0.0002
685 HYPERTENSION 33 0.0002
686 ERECTILE DYSFUNCTION 4 0.0002
687 INFUSION SITE PAIN 2 0.0002
688 ABDOMINAL DISCOMFORT 26 0.0002
689 UNRESPONSIVE TO STIMULI 4 0.0002
690 LACTIC ACIDOSIS 5 0.0002
691 EAR PAIN 3 0.0002
692 ATRIAL FIBRILLATION 15 0.0002
693 HAEMORRHOIDS 3 0.0002
694 BONE PAIN 9 0.0002
695 ORAL CANDIDIASIS 2 0.0002
696 PULMONARY CONGESTION 2 0.0002
697 DISORIENTATION 6 0.0002
698 APPETITE DISORDER 1 0.0002
699 AGITATION 11 0.0001
700 BRONCHIECTASIS 1 0.0001
701 TASTE DISORDER 3 0.0001
702 BODY TEMPERATURE INCREASED 3 0.0001
703 HAEMATURIA 5 0.0001
704 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
705 ORAL DISCOMFORT 2 0.0001
706 FEELING COLD 4 0.0001
707 APHONIA 2 0.0001
708 DEFAECATION URGENCY 1 0.0001
709 OXYGEN SATURATION DECREASED 8 0.0001
710 HYPONATRAEMIA 8 0.0001
711 SKIN REACTION 2 0.0001
712 DUODENAL ULCER 1 0.0001
713 SEASONAL ALLERGY 2 0.0001
714 HEPATOCELLULAR INJURY 2 0.0001
715 DIVERTICULUM 1 0.0001
716 PARALYSIS 2 0.0001
717 HYPERSOMNIA 4 0.0001
718 CARDIOGENIC SHOCK 2 0.0001
719 ACCIDENTAL UNDERDOSE 2 0.0001
720 DEEP VEIN THROMBOSIS 9 0.0001
721 INFECTION 20 0.0001
722 HYPERTHYROIDISM 2 0.0001
723 DERMATITIS BULLOUS 1 0.0001
724 FLUID OVERLOAD 2 0.0001
725 PERIPHERAL SWELLING 21 0.0001
726 INJECTION SITE MASS 5 0.0001
727 URINARY TRACT INFECTION 23 0.0001
728 CARDIAC ARREST 11 0.0001
729 HOT FLUSH 10 0.0001
730 BRADYCARDIA 7 0.0001
731 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
732 AORTIC ANEURYSM 1 0.0001
733 HEART RATE INCREASED 13 0.0001
734 NEPHROLITHIASIS 6 0.0001
735 SHOCK 3 0.0001
736 LYMPHOMA 2 0.0001
737 TENDONITIS 2 0.0001
738 CONCUSSION 1 0.0001
739 RASH PRURITIC 7 0.0001
740 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
741 DYSPNOEA 72 0.0001
742 PAIN 78 0.0001
743 ARRHYTHMIA 6 0.0001
744 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
745 DISEASE RECURRENCE 6 0.0001
746 PNEUMOTHORAX 2 0.0001
747 INFLUENZA 14 0.0001
748 OBESITY 2 0.0001
749 ATRIAL FLUTTER 1 0.0001
750 PRESYNCOPE 3 0.0001
751 DYSPEPSIA 12 0.0001
752 CONDITION AGGRAVATED 37 0.0001
753 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
754 EMBOLISM 1 0.0001
755 VIRAL INFECTION 4 0.0001
756 PNEUMONIA ASPIRATION 3 0.0001
757 SKIN DISORDER 4 0.0001
758 GAIT INABILITY 4 0.0001
759 CARDIO-RESPIRATORY ARREST 5 0.0001
760 TYPE 2 DIABETES MELLITUS 4 0.0001
761 ABDOMINAL PAIN LOWER 3 0.0001
762 CANDIDA INFECTION 2 0.0001
763 HEMIPARESIS 2 0.0001
764 CONFUSIONAL STATE 19 0.0001
765 HEPATIC ENZYME INCREASED 8 0.0001
766 BLOOD MAGNESIUM DECREASED 1 0.0001
767 MUCOSAL INFLAMMATION 3 0.0001
768 GASTRITIS 3 0.0001
769 COLD SWEAT 2 0.0001
770 HEAD DISCOMFORT 2 0.0001
771 CARDIOTOXICITY 1 0.0001
772 THROMBOSIS 9 0.0001
773 GASTROINTESTINAL DISORDER 10 0.0001
774 ANAL INCONTINENCE 1 0.0001
775 FREQUENT BOWEL MOVEMENTS 3 0.0001
776 GASTROENTERITIS VIRAL 2 0.0001
777 PALLOR 3 0.0001
778 SKIN LESION 3 0.0001
779 HAEMATOCHEZIA 6 0.0001
780 PROCEDURAL PAIN 3 0.0001
781 OROPHARYNGEAL PAIN 10 0.0001
782 MENTAL STATUS CHANGES 3 0.0001
783 SWELLING FACE 7 0.0001
784 DEMENTIA 3 0.0001
785 COGNITIVE DISORDER 5 0.0001
786 DIARRHOEA HAEMORRHAGIC 1 0.0001
787 HEPATIC CIRRHOSIS 2 0.0001
788 FRACTURE 2 0.0001
789 COLITIS 4 0.0001
790 FOOT FRACTURE 2 0.0001
791 BLOOD URINE PRESENT 2 0.0001
792 GASTRIC ULCER 2 0.0001
793 PULMONARY EMBOLISM 10 0.0001
794 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
795 MUSCULOSKELETAL DISORDER 2 0.0001
796 PNEUMONIA 34 0.0001
797 SLEEP APNOEA SYNDROME 2 0.0001
798 PRODUCTIVE COUGH 5 0.0001
799 BLOOD PRESSURE INCREASED 16 0.0001
800 DIZZINESS POSTURAL 1 0.0001
801 DYSSTASIA 3 0.0001
802 FALL 34 0.0001
803 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
804 UPPER LIMB FRACTURE 2 0.0001
805 INJURY 7 0.0001
806 MYOCARDIAL INFARCTION 17 0.0001
807 EAR DISCOMFORT 1 0.0001
808 RIB FRACTURE 2 0.0001
809 INFLAMMATION 5 0.0001
810 HAEMORRHAGE 10 0.0001
811 PANCREATITIS 5 0.0001
812 CHILLS 11 0.0001
813 BACK INJURY 1 0.0001
814 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
815 BLOOD GLUCOSE FLUCTUATION 1 0.0001
816 DENTAL CARIES 1 0.0001
817 DIZZINESS 45 0.0001
818 LIP SWELLING 3 0.0001
819 HEART RATE IRREGULAR 2 0.0001
820 MUSCULAR WEAKNESS 10 0.0001
821 CHOLECYSTECTOMY 1 0.0001
822 RASH 38 0.0001
823 CHEST PAIN 16 0.0001
824 RASH MACULAR 3 0.0001
825 DYSPHONIA 5 0.0001
826 PALPITATIONS 10 0.0001
827 BLOOD IRON DECREASED 1 0.0001
828 ATAXIA 1 0.0001
829 DEPRESSION 19 0.0001
830 CEREBROVASCULAR ACCIDENT 14 0.0001
831 INTERSTITIAL LUNG DISEASE 4 0.0001
832 MENTAL IMPAIRMENT 2 0.0001
833 UNDERDOSE 6 0.0001
834 COUGH 23 0.0001
835 DISCOMFORT 5 0.0001
836 CEREBRAL INFARCTION 2 0.0001
837 LUNG DISORDER 4 0.0001
838 ENCEPHALOPATHY 2 0.0001
839 CARDIOMEGALY 1 0.0001
840 DRUG DEPENDENCE 13 0.0001
841 OSTEONECROSIS OF JAW 2 0.0001
842 EPISTAXIS 6 0.0001
843 DYSARTHRIA 3 0.0001
844 HALLUCINATION 6 0.0001
845 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
846 SEIZURE 9 0.0001
847 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
848 MYALGIA 13 0.0001
849 NASOPHARYNGITIS 14 0.0001
850 INJECTION SITE HAEMORRHAGE 6 0.0001
851 PROSTATE CANCER 6 0.0001
852 LIMB INJURY 2 0.0001
853 BLINDNESS 3 0.0001
854 GAIT DISTURBANCE 14 0.0001
855 LUNG NEOPLASM MALIGNANT 3 0.0001
856 POLLAKIURIA 3 0.0001
857 HAEMOPTYSIS 2 0.0001
858 COORDINATION ABNORMAL 1 0.0001
859 PAIN IN EXTREMITY 21 0.0001
860 BLISTER 4 0.0001
861 BLINDNESS UNILATERAL 1 0.0001
862 BRONCHOSPASM 1 0.0001
863 HYPERHIDROSIS 9 0.0001
864 ANGINA PECTORIS 2 0.0001
865 MOBILITY DECREASED 5 0.0001
866 ANOSMIA 1 0.0001
867 MENTAL DISORDER 3 0.0001
868 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
869 RESPIRATORY FAILURE 5 0.0001
870 ANGIOEDEMA 3 0.0001
871 CARDIOMYOPATHY 1 0.0001
872 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
873 DYSGEUSIA 5 0.0001
874 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
875 RESPIRATORY DISORDER 2 0.0001
876 HYPOAESTHESIA 10 0.0001
877 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
878 EPILEPSY 2 0.0001
879 SKIN DISCOLOURATION 3 0.0001
880 ARTHRALGIA 27 0.0001
881 LIMB DISCOMFORT 2 0.0001
882 ANKLE FRACTURE 1 0.0001
883 FEMUR FRACTURE 2 0.0001
884 BRAIN FOG 1 0.0001
885 ANXIETY 18 0.0001
886 OCULAR HYPERAEMIA 3 0.0001
887 HEAD INJURY 2 0.0001
888 CYSTITIS 2 0.0001
889 MOVEMENT DISORDER 2 0.0001
890 RHINORRHOEA 4 0.0001
891 BACK DISORDER 1 0.0001
892 IMPAIRED HEALING 2 0.0001
893 INFLUENZA LIKE ILLNESS 5 0.0001
894 HEADACHE 38 0.0001
895 VISUAL ACUITY REDUCED 2 0.0001
896 TOXICITY TO VARIOUS AGENTS 10 0.0001
897 INJECTION SITE REACTION 4 0.0001
898 SPEECH DISORDER 3 0.0001
899 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
900 DRUG ERUPTION 1 0.0001
901 END STAGE RENAL DISEASE 1 0.0001
902 RESTLESSNESS 2 0.0001
903 ANAPHYLACTIC REACTION 3 0.0001
904 HYPERSENSITIVITY 10 0.0001
905 AGRANULOCYTOSIS 1 0.0001
906 BREAST CANCER 5 0.0001
907 WEIGHT INCREASED 12 0.0001
908 SWELLING 5 0.0001
909 CHOKING 1 0.0001
910 PRODUCT DOSE OMISSION ISSUE 15 0.0001
911 BLOOD PRESSURE ABNORMAL 1 0.0001
912 CYTOKINE RELEASE SYNDROME 1 0.0000
913 CARDIAC FAILURE CONGESTIVE 4 0.0000
914 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
915 EXTRA DOSE ADMINISTERED 2 0.0000
916 CHEST DISCOMFORT 5 0.0000
917 INSOMNIA 13 0.0000
918 ERYTHEMA 10 0.0000
919 DEVICE LEAKAGE 2 0.0000
920 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
921 INJECTION SITE PRURITUS 3 0.0000
922 PRURITUS 17 0.0000
923 MUSCLE SPASMS 8 0.0000
924 TINNITUS 2 0.0000
925 PRODUCT USE ISSUE 8 0.0000
926 DRUG INEFFECTIVE 56 0.0000
927 DYSPHAGIA 4 0.0000
928 RASH ERYTHEMATOUS 2 0.0000
929 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
930 DIABETIC KETOACIDOSIS 1 0.0000
931 JOINT SWELLING 5 0.0000
932 SOMNOLENCE 8 0.0000
933 CARDIOVASCULAR DISORDER 1 0.0000
934 FLUID RETENTION 2 0.0000
935 INJECTION SITE SWELLING 3 0.0000
936 HOSPITALISATION 6 0.0000
937 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
938 NERVOUSNESS 2 0.0000
939 DEAFNESS 1 0.0000
940 ECZEMA 2 0.0000
941 ARTHRITIS 3 0.0000
942 DEPRESSED MOOD 2 0.0000
943 DRY SKIN 5 0.0000
944 MEDICATION ERROR 2 0.0000
945 INJECTION SITE PAIN 11 0.0000
946 SKIN EXFOLIATION 3 0.0000
947 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
948 BALANCE DISORDER 3 0.0000
949 ACUTE MYOCARDIAL INFARCTION 1 0.0000
950 WHEEZING 2 0.0000
951 ADVERSE DRUG REACTION 3 0.0000
952 FEELING ABNORMAL 8 0.0000
953 CORONARY ARTERY DISEASE 1 0.0000
954 THERAPEUTIC RESPONSE DECREASED 2 0.0000
955 EMOTIONAL DISORDER 1 0.0000
956 DRUG-INDUCED LIVER INJURY 1 0.0000
957 NEUROPATHY PERIPHERAL 3 0.0000
958 AMNESIA 2 0.0000
959 INFUSION RELATED REACTION 2 0.0000
960 FEBRILE NEUTROPENIA 2 0.0000
961 TREMOR 5 0.0000
962 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
963 MEMORY IMPAIRMENT 4 0.0000
964 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
965 BURNING SENSATION 2 0.0000
966 THERAPY INTERRUPTED 2 0.0000
967 BRONCHITIS 2 0.0000
968 ASTHMA 3 0.0000
969 INCORRECT DOSE ADMINISTERED 6 0.0000
970 PARAESTHESIA 4 0.0000
971 DEVICE BREAKAGE 1 0.0000
972 VISUAL IMPAIRMENT 3 0.0000
973 INJECTION SITE ERYTHEMA 3 0.0000
974 TREATMENT FAILURE 2 0.0000
975 COMPLETED SUICIDE 2 0.0000
976 URTICARIA 4 0.0000
977 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
978 VISION BLURRED 3 0.0000
979 BLOOD CHOLESTEROL INCREASED 1 0.0000
980 MIGRAINE 2 0.0000
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
982 BLADDER CANCER 1 0.0000
983 DEVICE MALFUNCTION 1 0.0000
984 DRUG INTERACTION 2 0.0000
985 DRUG ABUSE 1 0.0000
986 DEVICE ISSUE 1 0.0000
987 ADVERSE EVENT 1 0.0000